Tripeptide-29 (200mg) — Research Peptide

For Research Use Only. Tripeptide-29 is not a drug, dietary supplement, or cosmetic ingredient as sold here, and is not intended to diagnose, treat, cure, or prevent any disease. Not for human or animal consumption.

What Is Tripeptide-29?

Tripeptide-29 is a synthetic three-amino-acid sequence — glycine-proline-hydroxyproline (Gly-Pro-Hyp) — designed to mimic the repeating structural motif found in natural collagen. Because of this minimal, well-defined structure, it’s commonly used in laboratory settings as a model compound for studying collagen behavior at the molecular level, rather than as a finished topical or injectable product.

Researchers select Tripeptide 29 specifically because its small size and simple sequence make it easier to isolate specific effects — like how a single repeat unit influences triple-helix formation — compared to working with full-length collagen or larger peptide fragments.

What Does the Research Say? (Tripeptide-29 Benefits in Studies)

Within in vitro and laboratory research models, Tripeptide-29 has been studied for several mechanisms relevant to dermal and connective-tissue biology, including:

• Collagen synthesis modulation — Several lab studies report measurable increases in type I collagen gene expression in fibroblast cell cultures exposed to Tripeptide-29, with some studies citing substantial increases in collagen output after 48-hour exposure windows.
• MMP enzyme activity — Research has examined Tripeptide-29’s potential to reduce activity of matrix metalloproteinases (MMP-1, MMP-3, MMP-9), enzymes associated with the breakdown of the extracellular matrix.
• Oxidative stress pathways — Some studies model Tripeptide-29 as a free-radical scavenger, examining its role in mitigating reactive oxygen species (ROS) in cellular environments.
• DPP-IV inhibition — Early research suggests the Gly-Pro-Hyp sequence may competitively inhibit dipeptidyl peptidase-IV (DPP-IV), an enzyme that breaks down short collagen-derived peptides.
• Collagen receptor interaction (GPVI) — Laboratory investigations have looked at Tripeptide 29 as a partial agonist of GPVI, a receptor involved in platelet-collagen interaction and clot formation, making it a compound of interest in vascular and wound-healing research models.
• Elastin and AGE-related research — Some studies explore its association with elastin synthesis and reduction of advanced glycation end-products (AGEs) in dermal fibroblast models.

These findings come from preclinical, in vitro, and benchtop research — they describe what has been observed in controlled laboratory conditions, not outcomes in humans, and should not be interpreted as claims about real-world skin or health effects.

Tripeptide-29 vs. Related Peptides

Researchers sometimes compare Tripeptide 29 against other short collagen-related peptides to isolate sequence-specific effects:

(Replace with your actual catalog comparisons/links if you stock these.)

Research Applications

Tripeptide-29 is typically incorporated into experimental designs involving:

• Fibroblast activation and collagen fiber assembly studies
• Extracellular matrix (ECM) and tissue scaffold research
• Platelet–collagen interface and clotting-pathway studies
• Biomaterial functionalization for synthetic implant research (bone, cartilage, dental)
• Comparative studies against other collagen-derived peptide fragments

Research Handling & Reconstitution Notes

The following reflects general laboratory handling practices reported in peptide research literature — not instructions for human use:

• Store lyophilized powder at [-20°C], protected from light and moisture, until reconstitution.
• Once reconstituted in [bacteriostatic water / appropriate solvent] for laboratory use, store per standard peptide stability protocols and use within the timeframe established by your lab’s SOPs.
• Concentrations used across published in vitro studies vary by experimental design; researchers should consult the specific study protocol relevant to their work rather than treating any single concentration as a standard.

Reported Observations in Research Literature (Side Effects / Safety Data)

Because Tripeptide-29 is studied exclusively in controlled lab environments, there is no established human safety or side-effect profile. Any “side effects” referenced in forums or third-party discussion (including community discussion on platforms like Reddit) reflect anecdotal, non-verified reports and are not based on clinical data. This product is not evaluated or approved for human use, and no safety claims are made or implied for human application.

Quality & Documentation

• Purity: [99%+], verified via [HPLC/Mass Spectrometry]
• Certificate of Analysis (COA): Available with every batch — [link/download]
• Manufactured/tested in: [Country/Facility]
• Packaging: [200mg] sterile lyophilized vial

Frequently Asked Questions

Is Tripeptide-29 approved for human use? No. Tripeptide 29 is sold strictly for laboratory and research purposes and has not been evaluated for safety or efficacy in humans or animals.

What is the difference between Tripeptide 29 and Tripeptide-1 Copper Acetate? Tripeptide-29 (Gly-Pro-Hyp) is studied primarily for collagen-mimicry and ECM research, while Tripeptide-1 Copper Acetate is a copper-peptide complex studied in different signaling contexts. They are structurally and functionally distinct compounds.

Does Tripeptide-29 come in serum or topical form? As sold here, Tripeptide-29 is supplied as a lyophilized research powder, not a finished topical serum or skincare product. Any topical or skincare-finished formulations referencing Tripeptide-29 are separate consumer products, not laboratory research material.

What purity level does this product ship at? This batch ships at [99%+] purity, confirmed by [HPLC testing], with a Certificate of Analysis provided for every order.